Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles